BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21446230)

  • 1. Scleroderma overlap syndrome.
    Balbir-Gurman A; Braun-Moscovici Y
    Isr Med Assoc J; 2011 Jan; 13(1):14-20. PubMed ID: 21446230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare case of systemic autoimmune disease with intricate features of systemic sclerosis, lupus, polymyositis and rheumatoid arthritis. Overlap syndrome or mixed connective tissue disease?
    Radulescu D; Pripon S; Ciovicescu F; Constantea NA
    Acta Reumatol Port; 2007; 32(3):292-7. PubMed ID: 17932479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mixed connective tissue disease and overlap syndrome].
    Nishimaki T
    Nihon Rinsho; 1999 Feb; 57(2):355-9. PubMed ID: 10078004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Undifferentiated connective tissue disease].
    Bodolay E; Szegedi G
    Orv Hetil; 2009 May; 150(19):867-72. PubMed ID: 19403430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.
    Alarcón-Segovia D; Cardiel MH
    J Rheumatol; 1989 Mar; 16(3):328-34. PubMed ID: 2724251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
    Lundberg I; Hedfors E
    J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overlapping syndrome].
    Tanimoto K
    Nihon Rinsho; 1992 Mar; 50(3):625-8. PubMed ID: 1588760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue diseases versus overlap syndrome.
    Malaviya AN; Narayanan K; Khan KM; Tiwari SC
    J Assoc Physicians India; 1984 Jul; 32(7):555-9. PubMed ID: 6501192
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
    Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
    Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlap syndromes.
    Fiori G; Pignone A; Cerinic MM
    Reumatizam; 2002; 49(2):12-5. PubMed ID: 12476753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features of undifferentiated connective tissue diseases: analysis of 145 patients].
    Zhang XW; Liu X; Li ZG
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2458-61. PubMed ID: 17156671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nail changes in connective tissue diseases: do nail changes provide clues for the diagnosis?
    Tunc SE; Ertam I; Pirildar T; Turk T; Ozturk M; Doganavsargil E
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):497-503. PubMed ID: 17373977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Occurrence of autoantibodies and the clinical course of mixed connective tissue disease, systemic scleroderma, dermatomyositis, polymyositis and Sjögren's syndrome].
    Prokop J; Zietkiewicz E; Słomski R
    Przegl Dermatol; 1986; 73(4):327-31. PubMed ID: 3333867
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse.
    Amigues JM; Cantagrel A; Abbal M; Mazieres B
    J Rheumatol; 1996 Dec; 23(12):2055-62. PubMed ID: 8970041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjogren's syndrome in SLE: Part 2. An examination of the clinical significance of Sjogren's syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma.
    Grennan DM; Ferguson M; Ghobarey AE; Williamson J; Dick WC; Buchanan WW
    N Z Med J; 1977 Oct; 86(598):376-9. PubMed ID: 272547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musculoskeletal Manifestations of Non-RA Connective Tissue Diseases: Scleroderma, Systemic Lupus Erythematosus, Still's Disease, Dermatomyositis/Polymyositis, Sjögren's Syndrome, and Mixed Connective Tissue Disease.
    Jacques T; Sudoł-Szopińska I; Larkman N; O'Connor P; Cotten A
    Semin Musculoskelet Radiol; 2018 Apr; 22(2):166-179. PubMed ID: 29672805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatic diseases and Klinefelter's syndrome.
    Rovenský J; Imrich R; Lazúrová I; Payer J
    Ann N Y Acad Sci; 2010 Apr; 1193():1-9. PubMed ID: 20398000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity.
    Cappelli S; Bellando Randone S; Martinović D; Tamas MM; Pasalić K; Allanore Y; Mosca M; Talarico R; Opris D; Kiss CG; Tausche AK; Cardarelli S; Riccieri V; Koneva O; Cuomo G; Becker MO; Sulli A; Guiducci S; Radić M; Bombardieri S; Aringer M; Cozzi F; Valesini G; Ananyeva L; Valentini G; Riemekasten G; Cutolo M; Ionescu R; Czirják L; Damjanov N; Rednic S; Matucci Cerinic M
    Semin Arthritis Rheum; 2012 Feb; 41(4):589-98. PubMed ID: 21959290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.